Internet-based Exposure Therapy for Panic Disorder: A Randomized Controlled Pilot Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 61
- 试验地点
- 1
- 主要终点
- Panic Disorder Severity Scale - Self rated (PDSS-SR)
研究概览
简要总结
The purpose of this study is examine if an internet-based exposure therapy based on inhibitory learning is feasible, acceptable and effective in reducing panic symptoms amongst patients who suffer from panic disorder and agoraphobia.
详细描述
Trial objectives: Primary objective is to examine if an internet-based exposure therapy based on inhibitory learning is effective in reducing panic symptoms. The secondary objective is to study if the protocol is feasible and acceptable. Secondary objective is measured is examined on 1) number of participants completing the study protocol, 2) participants' satisfaction with the treatment, 3) therapists' ratings of acceptability. The aim of this study is to assess the feasibility, and pilot the design and delivery of a RCT that will subsequently form the framework for a larger RCT to evaluate the effectiveness of an exposure protocol based on inhibitory learning.
Trial Design: Randomized controlled pilot study with two groups randomly assigned to either Internet-based exposure therapy based on the principles of inhibitory learning or Internet-based exposure therapy based on the principles of habituation Duration: Eight weeks Primary Endpoint: Change in panic symptoms from baseline to Week 8. Efficacy Parameters: Panic Disorder Severity Scale - Self rated (PDSS-SR) Safety Parameters: Adverse Events is assessed weekly via the internet. Description of Trial Subjects: Patients > 18 years old with a PDSS-SR score more than 6 points Number of Subjects: 80
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Outpatients
- •≥ 18 years
- •Situated in Sweden
- •Informed consent
- •Panic Disorder Severity Scale - self rated score more than 6 points
排除标准
- •Substance dependence during the last six months
- •Post traumatic stress disorder, bipolar disorder or psychosis
- •Symptoms better explained by axis 2 diagnosis (e.g. autism or borderline personality disorder)
- •MADRS-S score above 25 points
- •Psychotropic medication changes within one months prior to treatment that could affect target symptoms.
- •Received exposure based Cognitive behavior therapy (CBT) for pathological worry the last 2 years
研究组 & 干预措施
Inhibitory learning based treatment
The experimental group will go through Internet-based treatment. The exposure treatment is 8 weeks long and based on the principles of inhibitory learning, i.e. the participant is instructed to stay in the frightening situation until his/her expectancy has been maximally violated.
干预措施: Internet-based cognitive-behavior therapy (Behavioral)
Habituation based treatment
The active comparator group will also go through Internet-based treatment. The exposure treatment is 8 weeks long and based on the principles of emotional processing theory, i.e. the participant is instructed to stay in the frightening situation until anxiety has declined (habituated).
干预措施: Internet-based cognitive-behavior therapy (Behavioral)
结局指标
主要结局
Panic Disorder Severity Scale - Self rated (PDSS-SR)
时间窗: Week 0, Week 8
Change in panic symptoms from baseline to Week 8
次要结局
- Client Satisfaction Questionnaire (CSQ)(Week 8)
- Anxiety Sensitivity Index (ASI)(Week 0, Week 8)
- Patient Health Questionnaire (PHQ-9)(Week 0, Week 8)
- HA-NI-SSD Symptom Preoccupation Scale - testversion (SPSt)(Week 0, Week 8)
- Body Sensations Questionnaire (BSQ)(Week 0, Week 8)
- WHO Disability Assessment Schedule 2.0 (WHODAS 2.0)(Week 0, Week 8)
- Adverse events scale(Week 8)
- Credibility/Expectancy Questionnaire (CEQ)(Week 2)
- Brunnsviken Quality of Life Questionnaire (BBQ)(Week 0, Week 8)
- Agoraphobic Cognitions Questionnaire (ACQ)(Week 0, Week 8)
- Generalised Anxiety Disorder Assessment (GAD-7)(Week 0, Week 8)
- The Cardiac Anxiety Questionnaire (CAQ)(Week 0, Week 8)
研究者
Erik Andersson
PhD, psychologist
Karolinska Institutet